Kontio Pharma Oy
Kontio Pharma Oy's registered office is Pori. It is a limited company. The company was established on 2024-04-09. It operates in the industry of retail sale of cosmetic and toilet articles. In its latest retained statement for 2025-12-31, revenue was €3,495,035 and operating profit was €471,968.
About Kontio Pharma Oy
Financial position and key figures for the company.
Kontio Pharma Oy's location municipality is Pori. It is a limited company. The company was established on 2024-04-09. It operates in the industry of retail sale of cosmetic and toilet articles. In its latest retained statement for 2025-12-31, revenue was €3,495,035 and operating profit was €471,968. The latest retained financial statement for 2025-12-31 shows revenue of €3,495,035 and profit for the financial year of €378,441. Based on the latest retained statement, revenue growth was +44.9%, operating margin was +13.5%, and equity ratio was +90.2%.
Extended business activity
A longer directory- or registry-backed activity description that complements the short registry industry label.
Yhtiön toimiala on terveystuotteiden, lääkkeiden käyttöön tarvittavien välineiden ja tarvikkeiden, nikotiinivalmisteiden, luontaistuotteiden, elintarvikkeiden ja kosmeettisten valmisteiden ja muiden ns. vapaakaupan tuotteiden vähittäiskauppa, tukkukauppa, valmistus, maahantuonti ja maastavienti. Yhtiön toimialaan kuuluvat myös lääkehoidon tukipalvelut, kosmetologin palvelut, konsultointi- ja koulutuspalvelut ja henkilöstönvuokraus. Lisäksi yhtiön toimialaan kuuluvat kiinteistöjen ja maa-alueiden, osuuksien, osakkeiden ja muiden arvopapereiden ostaminen, hallitseminen ja myyminen.
Financial highlights
Key figures from the latest financial period.
2025-12-31
Financial ratios
Financial ratios based on financial statement data. Source: Yhdistetty lähde.
| Ratio | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Equity ratio | 77.7 % | 90.2 % |
| Current ratio | 4.30x | 9.25x |
| Operating profit margin | 14.6 % | 13.5 % |
Registry status and identifiers
Verified registry memberships and identifiers from the latest retained YTJ snapshot.
Responsible people
Public role relationships materialized from source observations.
Risk certificate
An open-data based company stability and risk signal.
BUSINESS.fi Luottoluokitus
Profile-specific risk signal based on open data
The grade can use open digital financial statement data together with registry signals.
Risk context
When open digital financial statements are unavailable, BUSINESS.fi shows registry, industry, and regional context.
Industry context is elevated based on normalized open statistical inputs.
The company has about 2 years of registry continuity.
Registry history, filing recency, and active register markings are still limited or mixed.
Registry timeline
Trade register notifications shown on a timeline.
Financial statements availability
Available statement periods and links into the retained/parsible financial statement surfaces. Use the latest statement page for deeper line-item detail.
Profile source and ownership
This company profile has not been claimed yet
Kontio Pharma Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.